Vicente Valero

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Mego M; De Giorgi U; Hsu L; Ueno N T; Valero V; Jackson S; Andreopoulou E; Kau S-W; Reuben J M; Cristofanilli M
Circulating tumor cells in metastatic inflammatory breast cancer.
De Giorgi Ugo; Valero Vicente; Rohren Eric; Dawood Shaheenah; Ueno Naoto T; Miller M Craig; Doyle Gerald V; Jackson Summer; Andreopoulou Eleni; Handy Beverly C; Reuben James M; Fritsche Herbert A; Macapinlac Homer A; Hortobagyi Gabriel N; Cristofanilli Massimo
Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
Liedtke Cornelia; Hatzis Christos; Symmans William Fraser; Desmedt Christine; Haibe-Kains Benjamin; Valero Vicente; Kuerer Henry; Hortobagyi Gabriel N; Piccart-Gebhart Martine; Sotiriou Christos; Pusztai Lajos
Genomic grade index is associated with response to chemotherapy in patients with breast cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Vicente Valero (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Mego M; De Giorgi U; Hsu L; Ueno N T; Valero V; Jackson S; Andreopoulou E; Kau S-W; Reuben J M; Cristofanilli M
Circulating tumor cells in metastatic inflammatory breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(11):1824-8.
2009: De Giorgi Ugo; Valero Vicente; Rohren Eric; Dawood Shaheenah; Ueno Naoto T; Miller M Craig; Doyle Gerald V; Jackson Summer; Andreopoulou Eleni; Handy Beverly C; Reuben James M; Fritsche Herbert A; Macapinlac Homer A; Hortobagyi Gabriel N; Cristofanilli Massimo
Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(20):3303-11.
2009: Liedtke Cornelia; Hatzis Christos; Symmans William Fraser; Desmedt Christine; Haibe-Kains Benjamin; Valero Vicente; Kuerer Henry; Hortobagyi Gabriel N; Piccart-Gebhart Martine; Sotiriou Christos; Pusztai Lajos
Genomic grade index is associated with response to chemotherapy in patients with breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(19):3185-91.
2009: Lu Jing; Steeg Patricia S; Price Janet E; Krishnamurthy Savitri; Mani Sendurai A; Reuben James; Cristofanilli Massimo; Dontu Gabriela; Bidaut Luc; Valero Vicente; Hortobagyi Gabriel N; Yu Dihua
Breast cancer metastasis: challenges and opportunities.
Cancer research 2009;69(12):4951-3.
2009: Agarwal Roshan; Gonzalez-Angulo Ana-Maria; Myhre Simen; Carey Mark; Lee Ju-Seog; Overgaard Jens; Alsner Jan; Stemke-Hale Katherine; Lluch Ana; Neve Richard M; Kuo Wen Lin; Sorlie Therese; Sahin Aysegul; Valero Vicente; Keyomarsi Khandan; Gray Joe W; Borresen-Dale Anne-Lise; Mills Gordon B; Hennessy Bryan T
Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(11):3654-62.
2009: Hennessy Bryan T; Gonzalez-Angulo Ana-Maria; Stemke-Hale Katherine; Gilcrease Michael Z; Krishnamurthy Savitri; Lee Ju-Seog; Fridlyand Jane; Sahin Aysegul; Agarwal Roshan; Joy Corwin; Liu Wenbin; Stivers David; Baggerly Keith; Carey Mark; Lluch Ana; Monteagudo Carlos; He Xiaping; Weigman Victor; Fan Cheng; Palazzo Juan; Hortobagyi Gabriel N; Nolden Laura K; Wang Nicholas J; Valero Vicente; Gray Joe W; Perou Charles M; Mills Gordon B
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.
Cancer research 2009;69(10):4116-24.
2009: Eralp Yesim; Smith Terry L; Altundag Kadri; Kau Shu-Wan; Litton Jennifer; Valero Vicente; Buzdar Aman; Hortobagyi Gabriel N; Arun Banu
Clinical features associated with a favorable outcome following neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger.
Journal of cancer research and clinical oncology 2009;135(1):141-8.
2009: Estephan Fadi; Valero Vicente; Esteva Francisco J; Mejia Jaime A; Frye Debra K; Ibrahim Nuhad K
Phase I study of prolonged-infusion gemcitabine combined with cyclophosphamide in patients with metastatic carcinoma of the breast: tolerability of an optimal dose schedule.
Oncology 2009;77(1):63-70.
2008: Moulder Stacy L; Symmans W Fraser; Booser Daniel J; Madden Timothy L; Lipsanen Cindy; Yuan Linda; Brewster Abenaa M; Cristofanilli Massimo; Hunt Kelly K; Buchholz Thomas A; Zwiebel James; Valero Vicente; Hortobagyi Gabriel N; Esteva Francisco J
Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(23):7909-16.
2008: Dawood Shaheenah; Broglio Kristine; Valero Vicente; Reuben James; Handy Beverly; Islam Rabiul; Jackson Summer; Hortobagyi Gabriel N; Fritsche Herbert; Cristofanilli Massimo
Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?
Cancer 2008;113(9):2422-30.
2008: Cristofanilli M; Morandi P; Krishnamurthy S; Reuben J M; Lee B-N; Francis D; Booser D J; Green M C; Arun B K; Pusztai L; Lopez A; Islam R; Valero V; Hortobagyi G N
Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlations.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(10):1713-9.
2008: Yang Wei-Tse; Dryden Mark; Broglio Kristine; Gilcrease Michael; Dawood Shaheenah; Dempsey Peter J; Valero Vicente; Hortobagyi Gabriel; Atchley Deann; Arun Banu
Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women.
Breast cancer research and treatment 2008;111(3):405-10.
2008: Atchley Deann P; Albarracin Constance T; Lopez Adriana; Valero Vicente; Amos Christopher I; Gonzalez-Angulo Ana Maria; Hortobagyi Gabriel N; Arun Banu K
Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(26):4282-8.
2008: Rivera Edgardo; Mejia Jaime A; Arun Banu K; Adinin Rosnie B; Walters Ronald S; Brewster Abenaa; Broglio Kristine R; Yin Guosheng; Esmaeli Bita; Hortobagyi Gabriel N; Valero Vicente
Phase 3 study comparing the use of docetaxel on an every-3-week versus weekly schedule in the treatment of metastatic breast cancer.
Cancer 2008;112(7):1455-61.
2008: Liedtke Cornelia; Cardone Luca; Tordai Attila; Yan Kai; Gomez Henry L; Figureoa Luis J Barajas; Hubbard Rebekah E; Valero Vicente; Souchon Eduardo A; Symmans W Fraser; Hortobagyi Gabriel N; Bardelli Alberto; Pusztai Lajos
PIK3CA-activating mutations and chemotherapy sensitivity in stage II-III breast cancer.
Breast cancer research : BCR 2008;10(2):R27.
2007: Beinart Garth; Gonzalez-Angulo Ana M; Broglio Kristine; Mejia Jaime; Ruggeri Anthony; Mininberg Eric; Hortobagyi Gabriel N; Valero Vicente
Clinical course of 771 patients with bilateral breast cancer: characteristics associated with overall and recurrence-free survival.
Clinical breast cancer 2007;7(11):867-74.
2007: Yang Wei Tse; Hennessy Bryan; Broglio Kristine; Mills Chadwick; Sneige Nour; Davis W Grant; Valero Vicente; Hunt Kelly K; Gilcrease Michael Z
Imaging differences in metaplastic and invasive ductal carcinomas of the breast.
AJR. American journal of roentgenology 2007;189(6):1288-93.
2007: Hanrahan Emer O; Gonzalez-Angulo Ana M; Giordano Sharon H; Rouzier Roman; Broglio Kristine R; Hortobagyi Gabriel N; Valero Vicente
Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(31):4952-60.
2007: Vogel Kristen J; Atchley Deann P; Erlichman Julie; Broglio Kristine R; Ready Kaylene J; Valero Vicente; Amos Christopher I; Hortobagyi Gabriel N; Lu Karen H; Arun Banu
BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(29):4635-41.
2007: Symmans W Fraser; Peintinger Florentia; Hatzis Christos; Rajan Radhika; Kuerer Henry; Valero Vicente; Assad Lina; Poniecka Anna; Hennessy Bryan; Green Marjorie; Buzdar Aman U; Singletary S Eva; Hortobagyi Gabriel N; Pusztai Lajos
Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(28):4414-22.
2007: Cristofanilli Massimo; Valero Vicente; Buzdar Aman U; Kau Shu-Wan; Broglio Kristine R; Gonzalez-Angulo Ana Maria; Sneige Nour; Islam Rabiul; Ueno Naoto T; Buchholz Thomas A; Singletary Sonja E; Hortobagyi Gabriel N
Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease.
Cancer 2007;110(7):1436-44.
2007: Arun Banu; Valero Vicente; Logan Catherine; Broglio Kristine; Rivera Edgardo; Brewster Abenaa; Yin Guosheng; Green Marjorie; Kuerer Henry; Gong Yun; Browne Doris; Hortobagyi Gabriel N; Sneige Nour
Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(16):4943-8.
2007: Bruera Eduardo; El Osta Badi; Valero Vicente; Driver Larry C; Pei Be-Lian; Shen Loren; Poulter Valerie A; Palmer J Lynn
Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3475-81.
2007: Mazouni Chafika; Peintinger Florentia; Wan-Kau Shu; Andre Fabrice; Gonzalez-Angulo Ana M; Symmans W Fraser; Meric-Bernstam Funda; Valero Vicente; Hortobagyi Gabriel N; Pusztai Lajos
Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2650-5.
2007: Sher Taimur; Hennessy Bryan T; Valero Vicente; Broglio Krisitine; Woodward Wendy A; Trent Jonathan; Hunt Kelly K; Hortobagyi Gabriel N; Gonzalez-Angulo Ana M
Primary angiosarcomas of the breast.
Cancer 2007;110(1):173-8.
2007: Gong Yun; Yan Kai; Lin Feng; Anderson Keith; Sotiriou Christos; Andre Fabrice; Holmes Frankie A; Valero Vicente; Booser Daniel; Pippen John E; Vukelja Svetislava; Gomez Henry; Mejia Jaime; Barajas Luis J; Hess Kenneth R; Sneige Nour; Hortobagyi Gabriel N; Pusztai Lajos; Symmans W Fraser
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study.
The lancet oncology 2007;8(3):203-11.
2007: Yang Wei Tse; Hennessy Bryan T J; Dryden Mark J; Valero Vicente; Hunt Kelly K; Krishnamurthy Savitri
Mammary angiosarcomas: imaging findings in 24 patients.
Radiology 2007;242(3):725-34.
2007: Cristofanilli Massimo; Broglio Kristine R; Guarneri Valentina; Jackson Summer; Fritsche Herbert A; Islam Rabiul; Dawood Shaheenah; Reuben James M; Kau Shu-Wan; Lara Juanita M; Krishnamurthy Saviti; Ueno Naoto T; Hortobagyi Gabriel N; Valero Vincente
Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden.
Clinical breast cancer 2007;7(6):471-9.
2007: Huang Eugene H; Strom Eric A; Valero Vicente; Fornage Bruno; Perkins George H; Oh Julia L; Yu Tse-Kuan; Tereffe Welela; Woodward Wendy A; Hunt Kelly K; Meric-Bernstam Funda; Sahin Aysegul A; Bedrosian Isabelle; Hortobagyi Gabriel N; Buchholz Thomas A
Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis.
International journal of radiation oncology, biology, physics 2007;67(2):490-6.
2007: Buzdar Aman U; Valero Vicente; Ibrahim Nuhad K; Francis Deborah; Broglio Kristine R; Theriault Richard L; Pusztai Lajos; Green Marjorie C; Singletary Sonja E; Hunt Kelly K; Sahin Aysegul A; Esteva Francisco; Symmans William F; Ewer Michael S; Buchholz Thomas A; Hortobagyi Gabriel N
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(1):228-33.
2007: Esteva Francisco J; Wang Jing; Lin Feng; Mejia Jaime A; Yan Kai; Altundag Kadri; Valero Vicente; Buzdar Aman U; Hortobagyi Gabriel N; Symmans W Fraser; Pusztai Lajos
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer.
Breast cancer research : BCR 2007;9(6):R87.
2006: Basen-Engquist Karen; Taylor Cindy L Carmack; Rosenblum Carol; Smith Murray A; Shinn Eileen H; Greisinger Anthony; Gregg Xylina; Massey Pamela; Valero Vicente; Rivera Edgardo
Randomized pilot test of a lifestyle physical activity intervention for breast cancer survivors.
Patient education and counseling 2006;64(1-3):225-34.
2006: Blancas I; García-Puche J L; Bermejo B; Hanrahan E O; Monteagudo C; Martínez-Agulló A; Rouzier R; Hennessy B T; Valero V; Lluch A
Low number of examined lymph nodes in node-negative breast cancer patients is an adverse prognostic factor.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(11):1644-9.
2006: Rivera Edgardo; Meyers Christina; Groves Morris; Valero Vicente; Francis Deborah; Arun Banu; Broglio Kristine; Yin Guosheng; Hortobagyi Gabriel N; Buchholz Thomas
Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma.
Cancer 2006;107(6):1348-54.
2006: Guarneri Valentina; Lenihan Daniel J; Valero Vicente; Durand Jean-Bernard; Broglio Kristine; Hess Kenneth R; Michaud Laura Boehnke; Gonzalez-Angulo Ana M; Hortobagyi Gabriel N; Esteva Francisco J
Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the M.D. Anderson Cancer Center experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4107-15.
2006: Hess Kenneth R; Anderson Keith; Symmans W Fraser; Valero Vicente; Ibrahim Nuhad; Mejia Jaime A; Booser Daniel; Theriault Richard L; Buzdar Aman U; Dempsey Peter J; Rouzier Roman; Sneige Nour; Ross Jeffrey S; Vidaurre Tatiana; Gómez Henry L; Hortobagyi Gabriel N; Pusztai Lajos
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(26):4236-44.
2006: Cristofanilli Massimo; Krishnamurthy Savitri; Guerra Laura; Broglio Kristine; Arun Banu; Booser Daniel J; Menander Kerstin; Van Wart Hood Jill; Valero Vicente; Hortobagyi Gabriel N
A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer: safety, efficacy, and biologic activity of a novel gene-therapy approach.
Cancer 2006;107(5):935-44.
2006: Esmaeli Bita; Amin Sapna; Valero Vicente; Adinin Rosnie; Arbuckle Rebecca; Banay Roberto; Do Kim-Anh; Rivera Edgardo
Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3619-22.
2006: Hanrahan Emer O; Broglio Kristine; Frye Deborah; Buzdar Aman U; Theriault Richard L; Valero Vicente; Booser Daniel J; Singletary Sonja E; Strom Eric A; Gajewski James L; Champlin Richard E; Hortobagyi Gabriel N
Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years.
Cancer 2006;106(11):2327-36.
2006: Hanrahan Emer O; Valero Vicente; Gonzalez-Angulo Ana M; Hortobagyi Gabriel N
Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(13):2113-22.
2006: Bruera Eduardo; Valero Vicente; Driver Larry; Shen Loren; Willey Jie; Zhang Tao; Palmer J Lynn
Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(13):2073-8.
2006: Hennessy B T; Giordano S; Broglio K; Duan Z; Trent J; Buchholz T A; Babiera G; Hortobagyi G N; Valero V
Biphasic metaplastic sarcomatoid carcinoma of the breast.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(4):605-13.
2006: Chedid Silwan; Rivera Edgardo; Frye Debbie K; Ibrahim Nuhad; Esteva Francisco; Valero Vicente; Hortobagyi Gabriel; Mettinger Karl L; Cristofanilli Massimo
Minimal clinical benefit of single agent Orathecin (Rubitecan) in heavily pretreated metastatic breast cancer.
Cancer chemotherapy and pharmacology 2006;57(4):540-4.
2006: Guarneri Valentina; Broglio Kristine; Kau Shu-Wan; Cristofanilli Massimo; Buzdar Aman U; Valero Vicente; Buchholz Thomas; Meric Funda; Middleton Lavinia; Hortobagyi Gabriel N; Gonzalez-Angulo Ana M
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(7):1037-44.
2006: Hennessy Bryan T; Gonzalez-Angulo Ana Maria; Hortobagyi Gabriel N; Cristofanilli Massimo; Kau Shu Wan; Broglio Kristine; Fornage Bruno; Singletary S Eva; Sahin Aysegul; Buzdar Aman U; Valero Vicente
Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy.
Cancer 2006;106(5):1000-6.
2005: Hennessy Bryan T; Hortobagyi Gabriel N; Rouzier Roman; Kuerer Henry; Sneige Nour; Buzdar Aman U; Kau Shu Wan; Fornage Bruno; Sahin Aysegul; Broglio Kristine; Singletary S Eva; Valero Vicente
Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9304-11.
2005: Symmans W F; Fiterman D J; Anderson S K; Ayers M; Rouzier R; Dunmire V; Stec J; Valero V; Sneige N; Albarracin C; Wu Y; Ross J S; Wagner P; Theriault R L; Arun B; Kuerer H; Hess K R; Zhang W; Hortobagyi G N; Pusztai L
A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding.
Endocrine-related cancer 2005;12(4):1059-69.
2005: Rouzier Roman; Pusztai Lajos; Delaloge Suzette; Gonzalez-Angulo Ana M; Andre Fabrice; Hess Kenneth R; Buzdar Aman U; Garbay Jean-Remi; Spielmann Marc; Mathieu Marie-Christine; Symmans W Fraser; Wagner Peter; Atallah David; Valero Vicente; Berry Donald A; Hortobagyi Gabriel N
Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(33):8331-9.
2005: Hennessy Bryan T; Krishnamurthy Savitri; Giordano Sharon; Buchholz Thomas A; Kau Shu W; Duan Zhigang; Valero Vicente; Hortobagyi Gabriel N
Squamous cell carcinoma of the breast.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):7827-35.
2005: Ewer Michael S; Vooletich Mary T; Durand Jean-Bernard; Woods Myrshia L; Davis Joseph R; Valero Vicente; Lenihan Daniel J
Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):7820-6.
2005: Davis William G; Hennessy Bryan; Babiera Gildy; Hunt Kelly; Valero Vicente; Buchholz Thomas A; Sneige Nour; Gilcrease Michael Z
Metaplastic sarcomatoid carcinoma of the breast with absent or minimal overt invasive carcinomatous component: a misnomer.
The American journal of surgical pathology 2005;29(11):1456-63.
2005: Gonzalez-Angulo Ana M; McGuire Sean E; Buchholz Thomas A; Tucker Susan L; Kuerer Henry M; Rouzier Roman; Kau Shu-Wan; Huang Eugene H; Morandi Paolo; Ocana Alberto; Cristofanilli Massimo; Valero Vicente; Buzdar Aman U; Hortobagyi Gabriel N
Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7098-104.
2005: Green Marjorie C; Buzdar Aman U; Smith Terry; Ibrahim Nuhad K; Valero Vicente; Rosales Marguerite F; Cristofanilli Massimo; Booser Daniel J; Pusztai Lajos; Rivera Edgardo; Theriault Richard L; Carter Cynthia; Frye Debra; Hunt Kelly K; Symmans W Fraser; Strom Eric A; Sahin Aysegul A; Sikov William; Hortobagyi Gabriel N
Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(25):5983-92.
2005: Hanrahan Emer O; Broglio Kristine R; Buzdar Aman U; Theriault Richard L; Valero Vicente; Cristofanilli Massimo; Yin Guosheng; Kau Shu-Wan C; Hortobagyi Gabriel N; Rivera Edgardo
Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors.
Cancer 2005;104(6):1158-71.
2005: Hanrahan Emer O; Hennessy Bryan T; Valero Vicente
Neoadjuvant systemic therapy for breast cancer: an overview and review of recent clinical trials.
Expert opinion on pharmacotherapy 2005;6(9):1477-91.
2005: Hennessy B T; Gauthier A M; Michaud L B; Hortobagyi G; Valero V
Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literature.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(8):1289-96.
2005: Montero Alberto J; Rouzier Roman; Lluch Ana; Theriault Richard L; Buzdar Aman U; Delaloge Suzette; Bermejo Begoñia; Le Monique; Kau Shu-Wan; Dunant Ariane; Arriagada Rodrigo; Spielmann Marc; Garcia-Conde Javier; Sahin Aysegul A; Singletary Sonja E; Hortobagyi Gabriel N; Valero Vicente
The natural history of breast carcinoma in patients with > or = 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstitutional retrospective study.
Cancer 2005;104(2):229-35.
2005: Huang Eugene H; Tucker Susan L; Strom Eric A; McNeese Marsha D; Kuerer Henry M; Hortobagyi Gabriel N; Buzdar Aman U; Valero Vicente; Perkins George H; Schechter Naomi R; Hunt Kelly K; Sahin Aysegul A; Buchholz Thomas A
Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
International journal of radiation oncology, biology, physics 2005;62(2):351-7.
2005: Gonzalez-Angulo Ana M; Broglio Kristine; Kau Shu-Wan; Eralp Yesmin; Erlichman Julie; Valero Vicente; Theriault Richard; Booser Daniel; Buzdar Aman U; Hortobagyi Gabriel N; Arun Banu
Women age < or = 35 years with primary breast carcinoma: disease features at presentation.
Cancer 2005;103(12):2466-72.
2005: Montero Alberto; Fossella Frank; Hortobagyi Gabriel; Valero Vicente
Docetaxel for treatment of solid tumours: a systematic review of clinical data.
The lancet oncology 2005;6(4):229-39.
2005: Chagpar Anees; Middleton Lavinia P; Sahin Aysegul A; Meric-Bernstam Funda; Kuerer Henry M; Feig Barry W; Ross Merrick I; Ames Frederick C; Singletary S Eva; Buchholz Thomas A; Valero Vincente; Hunt Kelly K
Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.
Cancer 2005;103(8):1581-6.
2005: Maru Dipen; Middleton Lavinia P; Wang Sijan; Valero Vicente; Sahin Aysegul
HER-2/neu and p53 overexpression as biomarkers of breast carcinoma in women age 30 years and younger.
Cancer 2005;103(5):900-5.
2005: Cristofanilli Massimo; Gonzalez-Angulo Ana; Sneige Nour; Kau Shu-Wan; Broglio Kristine; Theriault Richard L; Valero Vicente; Buzdar Aman U; Kuerer Henry; Buccholz Thomas A; Hortobagyi Gabriel N
Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(1):41-8.
2005: Montero Alberto; Booser Daniel; Esparza-Guerra Laura; Murray James; Rosales Marguerite; Hortobagyi Gabriel; Valero Vicente
Phase I trial of dose-dense docetaxel and doxorubicin with or without sargramostim in patients with metastatic breast cancer.
Drugs in R&D 2005;6(5):299-305.
2004: Anderson Karen O; Mendoza Tito R; Payne Richard; Valero Vicente; Palos Guadalupe R; Nazario Arlene; Richman Stephen P; Hurley Judith; Gning Ibrahima; Lynch Garrett R; Kalish Dorianne; Cleeland Charles S
Pain education for underserved minority cancer patients: a randomized controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(24):4918-25.
2004: Huang Eugene H; Tucker Susan L; Strom Eric A; McNeese Marsha D; Kuerer Henry M; Buzdar Aman U; Valero Vicente; Perkins George H; Schechter Naomi R; Hunt Kelly K; Sahin Aysegul A; Hortobagyi Gabriel N; Buchholz Thomas A
Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(23):4691-9.
2004: Li Zhiyong; Ibrahim Nuhad K; Wathen Jay K; Wang Michael; Mante Menchu Rosario P; Valero Vicente; Theriault Richard; Buzdar Aman U; Hortobagyi Gabriel N
Colitis in patients with breast carcinoma treated with taxane-based chemotherapy.
Cancer 2004;101(7):1508-13.
2004: Gonzalez-Angulo Ana M; Sneige Nour; Buzdar Aman U; Valero Vicente; Kau Shu-Wan; Broglio Kristine; Yamamura Yuko; Hortobagyi Gabriel N; Cristofanilli Massimo
p53 expression as a prognostic marker in inflammatory breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(18 Pt 1):6215-21.
2004: Shen Jeannie; Valero Vicente; Buchholz Thomas A; Singletary S Eva; Ames Frederick C; Ross Merrick I; Cristofanilli Massimo; Babiera Gildy V; Meric-Bernstam Funda; Feig Barry; Hunt Kelly K; Kuerer Henry M
Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy.
Annals of surgical oncology 2004;11(9):854-60.
2004: Blakely L Johnetta; Buzdar Aman; Chang Hsiu-Yin; Frye Debra; Theriault Richard; Valero Vicente; Rivera Edgardo; Booser Daniel; Kuritani Jun; Tsuda Masuhiro
A phase I and pharmacokinetic study of TAS-108 in postmenopausal female patients with locally advanced, locally recurrent inoperable, or progressive metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5425-31.
2004: Buchholz Thomas A; Huang Eugene H; Berry Donald; Pusztai Lajos; Strom Eric A; McNeese Marsha D; Perkins George H; Schechter Naomi R; Kuerer Henry M; Buzdar Aman U; Valero Vicente; Hunt Kelly K; Hortobagyi Gabriel N; Sahin Aysegul A
Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy.
International journal of radiation oncology, biology, physics 2004;59(5):1337-42.
2004: Ayers M; Symmans W F; Stec J; Damokosh A I; Clark E; Hess K; Lecocke M; Metivier J; Booser D; Ibrahim N; Valero V; Royce M; Arun B; Whitman G; Ross J; Sneige N; Hortobagyi G N; Pusztai L
Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2284-93.
2004: Garg Amit K; Strom Eric A; McNeese Marsha D; Buzdar Aman U; Hortobagyi Gabriel N; Kuerer Henry M; Perkins George H; Singletary S Eva; Hunt Kelly K; Sahin Asyegul; Schechter Naomi; Valero Vicente; Tucker Susan L; Buchholz Thomas A
T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
International journal of radiation oncology, biology, physics 2004;59(1):138-45.
2004: Rivera Edgardo; Valero Vicente; Francis Deborah; Asnis Aviva G; Schaaf Larry J; Duncan Barbara; Hortobagyi Gabriel N
Pilot study evaluating the pharmacokinetics, pharmacodynamics, and safety of the combination of exemestane and tamoxifen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(6):1943-8.
2004: Pusztai Lajos; Mendoza Tito R; Reuben James M; Martinez Monica M; Willey Jie S; Lara Juanita; Syed Abdul; Fritsche Herbert A; Bruera Eduardo; Booser Daniel; Valero Vicente; Arun Banu; Ibrahim Nuhad; Rivera Edgardo; Royce Melanie; Cleeland Charles S; Hortobagyi Gabriel N
Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy.
Cytokine 2004;25(3):94-102.
2003: Pusztai Lajos; Zhen Jim Hou; Arun Banu; Rivera Edgardo; Whitehead Clark; Thompson W Joseph; Nealy Kimberly M; Gibbs Amy; Symmans W Fraser; Esteva Francisco J; Booser Daniel; Murray James L; Valero Vicente; Smith Terry L; Hortobagyi Gabriel N
Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(18):3454-61.
2003: Rivera Edgardo; Valero Vicente; Arun Banu; Royce Melanie; Adinin Rosni; Hoelzer Karen; Walters Ronald; Wade James L; Pusztai Lajos; Hortobagyi Gabriel N
Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(17):3249-54.
2003: Esteva Francisco J; Rivera Edgardo; Cristofanilli Massimo; Valero Vicente; Royce Melanie; Duggal Anil; Colucci Philippe; DeJager Robert; Hortobagyi Gabriel N
A Phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with metastatic breast carcinoma.
Cancer 2003;98(5):900-7.
2003: Jones Kellie L; Valero Vicente
Capecitabine-induced pancreatitis.
Pharmacotherapy 2003;23(8):1076-8.
2003: Esmaeli Bita; Hidaji Lillie; Adinin Rosnie B; Faustina Misha; Coats Carol; Arbuckle Rebecca; Rivera Edgardo; Valero Vicente; Tu Shi-Ming; Ahmadi M Amir
Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy.
Cancer 2003;98(3):504-7.
2003: Trent Jonathan C; Valero Vicente; Booser Daniel J; Esparza-Guerra Laura T; Ibrahim Nuhad; Rahman Zia; Vernillet Laurent; Patel Shreyaskumar; David Cynthia L; Murray James L; Cristofanilli Massimo; Hortobagyi Gabriel N
A Phase I study of docetaxel plus cyclophosphamide in solid tumors followed by a Phase II study as first-line therapy in metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2426-34.
2003: Pusztai Lajos; Ayers Mark; Stec James; Clark Edward; Hess Kenneth; Stivers David; Damokosh Andrew; Sneige Nour; Buchholz Thomas A; Esteva Francisco J; Arun Banu; Cristofanilli Massimo; Booser Daniel; Rosales Marguerite; Valero Vicente; Adams Constantine; Hortobagyi Gabriel N; Symmans W Fraser
Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2406-15.
2003: Assikis Vasily; Buzdar Aman; Yang Ying; Smith Terry; Theriault Richard; Booser Daniel; Valero Vicente; Walters Ronald; Singletary Eva; Ames Frederick; Hortobagyi Gabriel
A phase III trial of sequential adjuvant chemotherapy for operable breast carcinoma: final analysis with 10-year follow-up.
Cancer 2003;97(11):2716-23.
2003: Davis Darren W; Buchholz Thomas A; Hess Kenneth R; Sahin Aysegul A; Valero Vincente; McConkey David J
Automated quantification of apoptosis after neoadjuvant chemotherapy for breast cancer: early assessment predicts clinical response.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(3):955-60.
2003: Meric Funda; Mirza Nadeem Q; Vlastos Georges; Buchholz Thomas A; Kuerer Henry M; Babiera Gildy V; Singletary S Eva; Ross Merrick I; Ames Frederick C; Feig Barry W; Krishnamurthy Savitri; Perkins George H; McNeese Marsha D; Strom Eric A; Valero Vicente; Hunt Kelly K
Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.
Cancer 2003;97(4):926-33.
2003: Buchholz Thomas A; Davis Darren W; McConkey David J; Symmans W Fraser; Valero Vicente; Jhingran Anuja; Tucker Susan L; Pusztai Lajos; Cristofanilli Massimo; Esteva Francisco J; Hortobagyi Gabriel N; Sahin Aysegul A
Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy.
Cancer journal (Sudbury, Mass.) 2003;9(1):33-41.
2002: Buchholz Thomas A; Stivers David N; Stec James; Ayers Mark; Clark Edward; Bolt Andrew; Sahin Aysegul A; Symmans W Fraser; Hess Kenneth R; Kuerer Henry M; Valero Vicente; Hortobagyi Gabriel N; Pusztai Lajos
Global gene expression changes during neoadjuvant chemotherapy for human breast cancer.
Cancer journal (Sudbury, Mass.) 2002;8(6):461-8.
2002: Giordano Sharon H; Booser Daniel J; Murray James L; Ibrahim Nuhad K; Rahman Zia U; Valero Vicente; Theriault Richard L; Rosales Marguerite F; Rivera Edgardo; Frye Debbie; Ewer Michael; Ordonez Nelson G; Buzdar Aman U; Hortobagyi Gabriel N
A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(11):3360-8.
2002: Valero Vicente; Buzdar Aman U; McNeese Marsha; Singletary Eva; Hortobagyi Gabriel N
Primary chemotherapy in the treatment of breast cancer: the University of Texas M. D. Anderson Cancer Center experience.
Clinical breast cancer 2002;3 Suppl 2():S63-8.
2002: Esmaeli Bita; Ahmadi M Amir; Rivera Edgardo; Valero Vicente; Hutto Toni; Jackson Denise M; Newman Robert A
Docetaxel secretion in tears: association with lacrimal drainage obstruction.
Archives of ophthalmology 2002;120(9):1180-2.
2002: Huang Eugene; McNeese Marsha D; Strom Eric A; Perkins George H; Katz Angela; Hortobagyi Gabriel N; Valero Vicente; Kuerer Henry M; Singletary S Eva; Hunt Kelly K; Buzdar Aman U; Buchholz Thomas A
Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer.
International journal of radiation oncology, biology, physics 2002;53(5):1225-33.
2002: Booser Daniel J; Esteva Francisco J; Rivera Edgardo; Valero Vicente; Esparza-Guerra Laura; Priebe Waldemar; Hortobagyi Gabriel N
Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer.
Cancer chemotherapy and pharmacology 2002;50(1):6-8.
2002: Buchholz Thomas A; Katz Angela; Strom Eric A; McNeese Marsha D; Perkins George H; Hortobagyi Gabriel N; Thames Howard D; Kuerer Henry M; Singletary S Eva; Sahin Aysegul A; Hunt Kelly K; Buzdar Aman U; Valero Vicente; Sneige Nour; Tucker Susan L
Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy.
International journal of radiation oncology, biology, physics 2002;53(4):880-8.
2002: Valero Vicente
Primary chemotherapy with docetaxel for the management of breast cancer.
Oncology (Williston Park, N.Y.) 2002;16(6 Suppl 6):35-43.
2002: Esmaeli Bita; Hortobagyi Gabriel N; Esteva Francisco J; Booser Daniel; Ahmadi M Amir; Rivera Edgardo; Arbuckle Rebecca; Delpassand Ebrahim; Guerra Laura; Valero Vicente
Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancer.
Ophthalmology 2002;109(6):1188-91.
2002: Giordano Sharon H; Valero Vicente; Buzdar Aman U; Hortobagyi Gabriel N
Efficacy of anastrozole in male breast cancer.
American journal of clinical oncology 2002;25(3):235-7.
2002: Rivera Edgardo; Valero Vicente; Cristofanilli Massimo; Frye Debra K; Booser Daniel J; Rosales Marguerite M; Hortobagyi Gabriel N
Phase I study of eniluracil and oral 5-fluorouracil in combination with docetaxel in the treatment of patients with metastatic breast carcinoma.
Cancer 2002;94(9):2321-6.
2002: Buzdar Aman U; Singletary S Eva; Valero Vicente; Booser Daniel J; Ibrahim Nuhad K; Rahman Zia; Theriault Richard L; Walters Ronald; Rivera Edgardo; Smith Terry L; Holmes Frankie A; Hoy Emma; Frye Debra K; Manuel Nikki; Kau Shu-Wan; McNeese Marsha D; Strom Eric; Thomas Eva; Hunt Kelly; Ames Fred; Berry Donald; Hortobagyi Gabriel N
Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):1073-9.
2002: Anderson Karen O; Richman Stephen P; Hurley Judith; Palos Guadalupe; Valero Vicente; Mendoza Tito R; Gning Ibrahima; Cleeland Charles S
Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control.
Cancer 2002;94(8):2295-304.
2002: Esteva Francisco J; Valero Vicente; Booser Daniel; Guerra Laura T; Murray James L; Pusztai Lajos; Cristofanilli Massimo; Arun Banu; Esmaeli Bita; Fritsche Herbert A; Sneige Nour; Smith Terry L; Hortobagyi Gabriel N
Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1800-8.
2002: Rivera Edgardo; Valero Vicente; Esteva Francisco J; Syrewicz Laura; Cristofanilli Massimo; Rahman Zia; Booser Daniel J; Hortobagyi Gabriel N
Lack of activity of stealth liposomal doxorubicin in the treatment of patients with anthracycline-resistant breast cancer.
Cancer chemotherapy and pharmacology 2002;49(4):299-302.
2002: Esmaeli B; Hortobagyi G; Esteva F; Valero V; Ahmadi M A; Booser D; Ibrahim N; Delpassand E; Arbuckle R
Canalicular stenosis secondary to weekly docetaxel: a potentially preventable side effect.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(2):218-21.
2002: Ibrahim Nuhad K; Rahman Zia; Valero Vicente; Murray James L; Frye Debra; Hortobagyi Gabriel N
Phase I study of vinorelbine and docetaxel with granulocyte colony-stimulating factor support in the treatment of metastatic breast cancer.
Cancer investigation 2002;20(1):29-37.
2001: Xiong Q; Valero V; Kau V; Kau S W; Taylor S; Smith T L; Buzdar A U; Hortobagyi G N; Theriault R L
Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience.
Cancer 2001;92(10):2523-8.
2001: Cristofanilli M; Buzdar A U; Sneige N; Smith T; Wasaff B; Ibrahim N; Booser D; Rivera E; Murray J L; Valero V; Ueno N; Singletary E S; Hunt K; Strom E; McNeese M; Stelling C; Hortobagyi G N
Paclitaxel in the multimodality treatment for inflammatory breast carcinoma.
Cancer 2001;92(7):1775-82.
2001: Buchholz T A; Hill B S; Tucker S L; Frye D K; Kuerer H M; Buzdar A U; McNeese M D; Singletary S E; Ueno N T; Pusztai L; Valero V; Hortobagyi G N
Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy.
Cancer journal (Sudbury, Mass.) 2001;7(5):413-20.
2001: Valero V; Perez E; Dieras V
Doxorubicin and taxane combination regimens for metastatic breast cancer: focus on cardiac effects.
Seminars in oncology 2001;28(4 Suppl 12):15-23.
2001: Hortobagyi G N; Ueno N T; Xia W; Zhang S; Wolf J K; Putnam J B; Weiden P L; Willey J S; Carey M; Branham D L; Payne J Y; Tucker S D; Bartholomeusz C; Kilbourn R G; De Jager R L; Sneige N; Katz R L; Anklesaria P; Ibrahim N K; Murray J L; Theriault R L; Valero V; Gershenson D M; Bevers M W; Huang L; Lopez-Berestein G; Hung M C
Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(14):3422-33.
2001: Esmaeli B; Valero V; Ahmadi M A; Booser D
Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect.
Ophthalmology 2001;108(5):994-5.
2001: Trent II J C; Benjamin R S; Valero V
Primary soft tissue sarcoma of the breast.
Current treatment options in oncology 2001;2(2):169-76.
2001: Rivera E; Valero V; Syrewicz L; Rahman Z; Esteva F J; Theriault R L; Rosales M M; Booser D; Murray J L; Bast R C; Hortobagyi G N;
Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1716-22.
2001: Ibrahim N K; Buzdar A U; Valero V; Dhingra K; Willey J; Hortobagyi G N
Phase I study of vinorelbine and paclitaxel by 3-hour simultaneous infusion with and without granulocyte colony-stimulating factor support in metastatic breast carcinoma.
Cancer 2001;91(4):664-71.
2001: Brito R A; Valero V; Buzdar A U; Booser D J; Ames F; Strom E; Ross M; Theriault R L; Frye D; Kau S W; Asmar L; McNeese M; Singletary S E; Hortobagyi G N
Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(3):628-33.
2001: Ibrahim N K; Valero V; Rahman Z; Theriault R L; Walters R S; Buzdar A U; Booser D J; Holmes F A; Murray J L; Willey J; Bast R; Hortobagyi G N
Phase I-II vinorelbine (Navelbine) by continuous infusion in patients with metastatic breast cancer: cumulative toxicities limit dose escalation.
Cancer investigation 2001;19(5):459-66.
2000: Rivera E; Holmes F A; Frye D; Valero V; Theriault R L; Booser D; Walters R; Buzdar A U; Dhingra K; Fraschini G; Hortobagyi G N
Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy.
Cancer 2000;89(11):2195-201.
2000: Michaud L B; Valero V; Hortobagyi G
Risks and benefits of taxanes in breast and ovarian cancer.
Drug safety : an international journal of medical toxicology and drug experience 2000;23(5):401-28.
2000: Hoff P M; Valero V; Buzdar A U; Singletary S E; Theriault R L; Booser D; Asmar L; Frye D; McNeese M D; Hortobagyi G N
Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy.
Cancer 2000;88(9):2054-60.
2000: Ibrahim N K; Valero V; Theriault R L; Willey J; Walters R S; Buzdar A U; Booser D J; Hortobagyi G N
Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer.
American journal of clinical oncology 2000;23(2):117-21.
2000: Anderson K O; Mendoza T R; Valero V; Richman S P; Russell C; Hurley J; DeLeon C; Washington P; Palos G; Payne R; Cleeland C S
Minority cancer patients and their providers: pain management attitudes and practice.
Cancer 2000;88(8):1929-38.
2000: Hortobagyi G N; Buzdar A U; Theriault R L; Valero V; Frye D; Booser D J; Holmes F A; Giralt S; Khouri I; Andersson B; Gajewski J L; Rondon G; Smith T L; Singletary S E; Ames F C; Sneige N; Strom E A; McNeese M D; Deisseroth A B; Champlin R E
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.
Journal of the National Cancer Institute 2000;92(3):225-33.
2000: Ibrahim N K; Sahin A A; Dubrow R A; Lynch P M; Boehnke-Michaud L; Valero V; Buzdar A U; Hortobagyi G N
Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer.
Lancet 2000;355(9200):281-3.
1999: Buzdar A U; Singletary S E; Theriault R L; Booser D J; Valero V; Ibrahim N; Smith T L; Asmar L; Frye D; Manuel N; Kau S W; McNeese M; Strom E; Hunt K; Ames F; Hortobagyi G N
Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(11):3412-7.
1999: Ibrahim N K; Rahman Z; Valero V; Willey J; Theriault R L; Buzdar A U; Murray J L; Bast R; Hortobagyi G N
Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma.
Cancer 1999;86(7):1251-7.
1999: Valero V; Buzdar A U; Theriault R L; Azarnia N; Fonseca G A; Willey J; Ewer M; Walters R S; Mackay B; Podoloff D; Booser D; Lee L W; Hortobagyi G N
Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluorouracil as first-line therapy in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1425-34.
1999: Holmes F A; Valero V; Walters R S; Theriault R L; Booser D J; Gibbs H; Fraschini G; Buzdar A U; Willey J; Frye D; Asmar L; Hortobagyi G N
Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I results.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(4):403-11.
1998: Pusztai L; Walters R S; Valero V; Theriault R L; Hortobagyi G N
Daily oral etoposide in patients with heavily pretreated metastatic breast cancer.
American journal of clinical oncology 1998;21(5):442-6.
1998: Valero V; Jones S E; Von Hoff D D; Booser D J; Mennel R G; Ravdin P M; Holmes F A; Rahman Z; Schottstaedt M W; Erban J K; Esparza-Guerra L; Earhart R H; Hortobagyi G N; Burris H A
A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3362-8.
1998: Walters R S; Holmes F A; Valero V; Esparza-Guerra L; Hortobagyi G N
Phase II study of ifosfamide and mesna in patients with metastatic breast cancer.
American journal of clinical oncology 1998;21(4):413-5.
1998: Diaz-Canton E A; Valero V; Rahman Z; Rodriguez-Monge E; Frye D; Smith T; Buzdar A U; Hortobagyi G N
Clinical course of breast cancer patients with metastases confined to the lungs treated with chemotherapy. The University of Texas M.D. Anderson Cancer Center experience and review of the literature.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(4):413-8.
1998: Valero V
Future direction of neoadjuvant therapy for breast cancer.
Seminars in oncology 1998;25(2 Suppl 3):36-41.
1998: Hoff P M; Valero V; Ibrahim N; Willey J; Hortobagyi G N
Hand-foot syndrome following prolonged infusion of high doses of vinorelbine.
Cancer 1998;82(5):965-9.
1997: Rahman Z; Champlin R; Rondon G; Frye D; Valero V; Mehra R; Hortobagyi G
Phase I/II study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer.
Seminars in oncology 1997;24(5 Suppl 17):S17-77-S17-80.
1997: Valero V
Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
Oncology (Williston Park, N.Y.) 1997;11(8 Suppl 8):34-6.
1997: Valero V
Docetaxel as single-agent therapy in metastatic breast cancer: clinical efficacy.
Seminars in oncology 1997;24(4 Suppl 13):S13-11-S13-18.
1997: Valero V
Docetaxel and cyclophosphamide in patients with advanced solid tumors.
Oncology (Williston Park, N.Y.) 1997;11(6 Suppl 6):21-3.
1997: Hoff P M; Valero V; Holmes F A; Whealin H; Hudis C; Hortobagyi G N
Paclitaxel-induced pancreatitis: a case report.
Journal of the National Cancer Institute 1997;89(1):91-3.
1996: Holmes F A; Madden T; Newman R A; Valero V; Theriault R L; Fraschini G; Walters R S; Booser D J; Buzdar A U; Willey J; Hortobagyi G N
Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2713-21.
1996: Valero V
Treatment of patients resistant to paclitaxel therapy.
Anti-cancer drugs 1996;7 Suppl 2():17-9.
1996: Duvic M; Lemak N A; Valero V; Hymes S R; Farmer K L; Hortobagyi G N; Trancik R J; Bandstra B A; Compton L D
A randomized trial of minoxidil in chemotherapy-induced alopecia.
Journal of the American Academy of Dermatology 1996;35(1):74-8.
1995: Valero V; Holmes F A; Walters R S; Theriault R L; Esparza L; Fraschini G; Fonseca G A; Bellet R E; Buzdar A U; Hortobagyi G N
Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(12):2886-94.
1995: Dhingra K; Fritsche H; Murray J L; LoBuglio A F; Khazaeli M B; Kelley S; Tepper M A; Grasela D; Buzdar A; Valero V
Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualin.
Cancer research 1995;55(14):3060-7.
1995: Ravdin P M; Valero V
Review of docetaxel (Taxotere), a highly active new agent for the treatment of metastatic breast cancer.
Seminars in oncology 1995;22(2 Suppl 4):17-21.
1994: Buzdar A U; Hortobagyi G N; Frye D; Ho D; Booser D J; Valero V; Holmes F A; Birmingham B K; Bui K; Yeh C
Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(1):50-4.
1994: Dhingra K; Valero V; Gutierrez L; Theriault R; Booser D; Holmes F; Buzdar A; Fraschini G; Hortobagyi G
Phase II study of deoxyspergualin in metastatic breast cancer.
Investigational new drugs 1994;12(3):235-41.
1993: Holmes F A; Valero V; Walters R S; Theriault R L; Booser D J; Fraschini G; Buzdar A U; Frye D; Gibbs H R; Hortobagyi G N
The M. D. Anderson Cancer Center experience with Taxol in metastatic breast cancer.
Journal of the National Cancer Institute. Monographs 1993;(15):161-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Vicente Valero

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Vicente Valero (preview)

All Publications